Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/2012
12/06/2012US20120308479 Brain Endothelial Cell Expression Patterns
12/06/2012US20120308478 Antibodies specific for claudin 6 (cldn6)
12/06/2012CA2874998A1 Methods, compositions, and kits for the treatment of cancer
12/06/2012CA2838158A1 Heterobifunctional linkers with polyethylene glycol segments and immune response modifier conjugates made therefrom
12/06/2012CA2838125A1 In situ antigen-generating cancer vaccine
12/06/2012CA2837736A1 Neutralizing prolactin receptor antibody mat3 and its therapeutic use
12/06/2012CA2837582A1 Genetic vaccines against hendra virus and nipah virus
12/06/2012CA2837556A1 Antibodies specific for tgf-beta
12/06/2012CA2837527A1 Fc receptor binding proteins
12/06/2012CA2837472A1 Rationally-designed anti-mullerian inhibiting substance type ii receptor antibodies
12/06/2012CA2837411A1 Rhamno-polysaccharide from enterococcus faecium clonal complex 17 and uses thereof
12/06/2012CA2837395A1 Immunogenic composition
12/06/2012CA2837393A1 Immunogenic composition
12/06/2012CA2837375A1 Needle-free administration of prrsv vaccines
12/06/2012CA2837279A1 Mutant replicon derived from genome of hepatitis c virus j6cf strain
12/06/2012CA2837222A1 Blood-stage malaria vaccine
12/06/2012CA2837125A1 Combined vaccines for prevention of porcine virus infections
12/06/2012CA2837042A1 A synergistic pharmaceutical combination for the treatment of squamous cell carcinoma of head and neck
12/06/2012CA2836947A1 Anti-emr1 antibodies
12/06/2012CA2836511A1 Matriptase inhibitors and uses thereof against orthomyxoviridae infections
12/05/2012EP2530462A1 Methods and kits for predicting tumor responses to antibodies against epidermal growth factor receptor (EGFR) and uses thereof
12/05/2012EP2530162A1 Biomolecule surface display and uses thereof
12/05/2012EP2530161A2 Process for producing poxviruses and poxvirus compositions
12/05/2012EP2530147A2 Influenza hemagglutinin and neuraminidase variants
12/05/2012EP2530091A1 Anti-dll3 antibody
12/05/2012EP2530090A2 Anti-IL-13R alpha 1 antibodies and their uses thereof
12/05/2012EP2530089A1 Neutralising prolactin receptor antibody Mat3 and its therapeutical use
12/05/2012EP2530087A2 Sequences of brachyspira, immunogenic composition, methods for preparation and use thereof
12/05/2012EP2529758A2 Vitamin receptor binding drug delivery conjugates
12/05/2012EP2529754A1 Antibodies binding to an intracellular PRL-1 or PRL-3 polypeptide
12/05/2012EP2529753A1 Pharmaceutical composition for treatment or prevention of osteoarthritis, and method of production therefor
12/05/2012EP2529752A1 Use for production of therapeutic agent or prophylactic agent for osteoarthritis
12/05/2012EP2529751A1 Injectable solution containing therapeutic agent for osteoarthritis
12/05/2012EP2529750A1 Combination vaccine with whole cell pertussis
12/05/2012EP2529749A1 Combination vaccine with acellular pertussis
12/05/2012EP2529748A2 Vaccine
12/05/2012EP2529747A2 Chimeric Newcastle Disease viruses presenting non-native surface proteins and uses thereof
12/05/2012EP2529619A2 Treating neurological disorders
12/05/2012EP2529010A1 Vaccinia virus mutants containing the major genomic deletions of mva
12/05/2012EP2528946A1 Methods of treating autoimmune diseases with dll4 antagonists
12/05/2012EP2528939A1 Recombinant proteins for use in vaccine, antibodies against said proteins, and diagnostic and therapeutic methods including the same
12/05/2012EP2528624A1 Extracellular ifi16 as therapeutic agents
12/05/2012EP2528623A2 Respiratory virus epitopes templated into double stranded coiled -coils and use thereof in immunization
12/05/2012EP2528622A2 Influenza virus epitopes templated into double-stranded coiled coils and use thereof in immunization
12/05/2012EP2528621A1 Modified tuberculosis antigens
12/05/2012EP2528620A1 Salmonella vaccine
12/05/2012EP2528614A1 Methods of treating glucose metabolism disorders
12/05/2012CN1437479B Recombinant intracellular pathogen vaccines and methods for use
12/05/2012CN102812047A Anti-C4.4a Antibodies And Uses Thereof
12/05/2012CN102812043A Method For Producing T Cell Receptor-like Monoclonal Antibodies And Uses Thereof
12/05/2012CN102811739A T Cell Activation Inhibitor, Pharmaceutical Composition Containing Same, And Screening Method For T Cell Activation Inhibiting Substance
12/05/2012CN102811738A Use for production of therapeutic agent or prophylactic agent for osteoarthritis
12/05/2012CN102811737A Pharmaceutical composition for treatment or prevention of osteoarthritis, and method of production therefor
12/05/2012CN102811736A Humanized Anti-IL-10 Antibodies For The Treatment Of Systemic Lupus Erythematosus (SLE)
12/05/2012CN102811735A Variants Of The Group-6 Allergens Of The Poaceae With Reduced Allergenicity By Mutagenesis Of Proline Residues
12/05/2012CN102811734A Vaccine vectors and methods of enhancing immune responses
12/05/2012CN102811733A Bacteremia-associated Antigen From Staphylococcus Aureus
12/05/2012CN102811732A Immunogens, Compositions And Uses Thereof, Method For Preparing Same
12/05/2012CN102807972A Hepatitis A virus purification method
12/05/2012CN102807621A Fusion protein containing diphtheria toxin non-toxic mutant cross-reacting material 197 (CRM197) or segment thereof
12/05/2012CN102807617A Antibodies to M-CSF
12/05/2012CN102807608A Peptide sequences and compositions
12/05/2012CN102805872A HBV-heat shock protein 70 fusion gene vaccine delivered by attenuated salmonella typhimurium, and preparation and application thereof
12/05/2012CN102805868A Method of treatment using ligand-immunogen conjugates
12/05/2012CN102805865A Eye drop administration device system and preparation
12/05/2012CN102805864A Newcastle disease and H9N2 subtype avian influenza bivalent inactivated vaccine and preparation method thereof
12/05/2012CN102805863A Preparation method of novel bunyavirus purification inactivated vaccine by culturing human diploid cell
12/05/2012CN102805862A Preparation method for SFTS bunyavirus purification and inactivation vaccines through VERO cell culture
12/05/2012CN101974072B Escherichia coli TolC antigen as well as antibody and application thereof
12/05/2012CN101918033B Increase of immune response and targeting by antigens and/or drug linkage
12/05/2012CN101885760B HIV-1gp120 gene consensus sequence optimized by codon and gp120 nucleic acid vaccine
12/05/2012CN101885757B Avian influenza hemagglutinin, epitope peptide, monoclonal antibodies for resisting avian influenza hemagglutinin and epitope peptide, and applications of monoclonal antibodies
12/05/2012CN101631800B Canine thymic stromal lymphopoietin protein and uses thereof
12/05/2012CN101495636B DNA vaccine for koi herpes virus (KHV) disease
12/05/2012CN101386641B Synthetic peptide vaccines for foot-and-mouth disease
12/05/2012CN101370517B Peptide derived from hepatitis C virus
12/05/2012CN101367869B Polypeptide for preventing, diagnosing and treating hepatitis E virus, and vaccine as diagnosis agent of the same
12/05/2012CN101291689B Vaccine stabilizing preparation of active antigen for large-scale inoculation system
12/05/2012CN101175509B Immunogenic compositions comprising lawsonia intracellularis
12/05/2012CN101133158B 人抗狂犬病抗体及其用途 Human anti-rabies antibodies and their use
12/04/2012US8324354 Streptococcal antigenic protein for use in generation of vaccines to prevent microorganismal infection
12/04/2012US8324352 Anti-inflammatory antibodies and uses therefor
12/04/2012US8324351 Fc variants with altered binding to FcRn
12/04/2012US8324345 HLA-binding peptide, precursor thereof, DNA fragment and recombinant vector encoding the same
12/04/2012US8324190 Treatment of proliferative disorders with amino-substituted (E)-2,6- dialkoxystyryl 4-substituted benzylsulfones
12/04/2012US8324175 Compositions and methods for the treatment of cancer
12/04/2012US8324148 Delivering to the subject a compound comprising a nuclear localization sequence of NF-kB such that nuclear importation of NF-kB is inhibited
12/04/2012US8323962 Molecules with extended half-lives, compositions and uses thereof
12/04/2012US8323961 HIV vaccines based on adenoviral vectors encoding Env from multiple clades of HIV
12/04/2012US8323959 Microorganisms for therapy
12/04/2012US8323668 Prevention and treatment of gram negative, flagellated bacterial infections
12/04/2012US8323667 Interaction of Moraxella catarrhalis with epithelial cells, extracellular matrix proteins and the complement system
12/04/2012US8323666 Botulinum toxin compositions
12/04/2012US8323665 Ricin A chain mutants lacking enzymatic activity as vaccines to protect against aerosolized ricin
12/04/2012US8323664 Live vaccine strains of Francisella
12/04/2012US8323663 Adenoviral vector-based foot-and-mouth disease vaccine
12/04/2012US8323662 Methods useful for generating highly mannosylated pseudotyped lentiviral vector particles comprising a Vpx protein
12/04/2012US8323661 Method for generating a stable recombinant modified vaccinia virus ankara (MVA) comprising human immunodeficiency virus (HIV) genes inserted into one or more intergenic regions (IGRs)
12/04/2012US8323660 Method for identification, isolation and production of antigens to a specific pathogen
12/04/2012US8323659 Method for diagnosing and/or treating tumor
1 ... 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 ... 1823